Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine
Radosław Mlak,Paweł Krawczyk,Marzanna Ciesielka,Iwona Homa,Tomasz Powrózek,Monika Prendecka+3 more-2015-07-28-Cancer Chemotherapy and Pharmacology
8PDF
TL;DRAbstract
Rare TT genotype of STMN1 gene may be an unfavorable predictive factor of chemotherapy based on platinum compounds and vinorelbine, in patients with NSCLC.
Chat with Paper
AI Agents for this Paper
Rare TT genotype of STMN1 gene may be an unfavorable predictive factor of chemotherapy based on platinum compounds and vinorelbine, in patients with NSCLC.
Keywords
VinorelbineOncologyVinblastineInternal medicineERCC1ChemotherapyGenotypeCancer research
Chat
Click to start Chat